Caplight Directory>Companies>OCON Therapeutics-preview>Ocon-therapeutics


OCON Therapeutics

OCON Therapeutics

Private
IsraelHealthcare & Life Scienceshttps://www.oconmed.com

Last Round

Early Funding

Jun 24, 2024

Total Funding Raised

$10M

Momentum Score

25 /100

Company Overview

OCON Therapeutics is a healthcare company specializing in intrauterine drug-delivery technology designed to treat various uterus-based conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

Intra-Uterine Ball (IUB) technology3D spherical intrauterine devicehormone-free copper IUDintrauterine drug-delivery platformlong-term reversible contraception (LARC)frameless intrauterine deviceintrauterine therapy for uterine pathologiesspherical endometrial ablation devicewomen's health medical device manufacturerintrauterine drug delivery for endometriosisintrauterine therapy for uterine fibroids

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OCON Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OCON Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 24, 2024
View all Funding Rounds

OCON Therapeutics Investors

Notable investors and investment history

InvestorRounds
Exerte PartnersEarly Funding
Israel Innovation AuthorityEarly Funding
Features CapitalEarly Funding
Astia AngelsEarly Funding
RH CapitalEarly Funding
View all Investors

OCON Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OCON Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OCON Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range31
Year Founded2020
Last FundingJun 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.